Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Shaw Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Battling Blood-Sucking Bugs
      • Unexpected Leads to Curb Addiction
      • Shaping Therapies for Sickle Cell Disease
      • The Mind’s Map Maker
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
The NIH Catalyst: A Publication About NIH Intramural Research

National Institutes of Health • Office of the Director | Volume 31 Issue 2 • March–April 2023

Our Shared Ancestry in African Genomes Can Be Harnessed to Improve Health For All

Ambroise Wonkam’s WALS Lecture

BY SREYA SANYAL, NIDCR

“Less than 2% of human genomes analyzed so far have been those of African people, despite the fact that Africa, where humans originated, contains more genetic diversity than any other continent,” medical geneticist Ambroise Wonkam wrote in a Nature commentary (Nature 590:209-211, 2021). He explained further at a Wednesday Afternoon Lecture last September that “to make genetic medicine truly equitable, we need to have representation of a wide genome [by starting] with our common ancestral genomes—genomes of the population of African ancestry.”

Ambroise Wonkam

CREDIT: JOHNS HOPKINS MEDICINE

Ambroise Wonkam, M.D., Ph.D.

Wonkam, who is a Professor of Genetic Medicine and Director of the McKusick-Nathans Institute and Department of Genetic Medicine at Johns Hopkins Medicine (Baltimore), is investigating the genetics of people from Africa to obtain a more thorough understanding of the genetic origins of diseases and other health conditions. The African genomes hold many secrets: There’s about 10% more DNA than in the human reference genome built from the Human Genome Project (Nature Genetics 51:30-35, 2019).

By gathering more information from African genomes, scientists can identify genes and variants that haven’t been found in previous studies, most of which are based on people of European descent. Wonkam and Charles Rotimi, the Scientific Director in the National Human Genome Research Institute, have collaborated on the Human Heredity and Health in Africa (H3Africa) consortium, which is partially funded by NIH and facilitates projects led by African scientists. The H3Africa initiative is helping to develop the infrastructure, resources, and training needed for African researchers to be competitive in genomic sciences. Projects have included population-based genomic studies of common, noncommunicable disorders such as heart and renal disease, as well as communicable diseases such as tuberculosis, and have identified three-million previously unidentified variants (Nature 592:E26, 2021).

Because most participants in genome-wide association studies are of European descent (they make up only 16% of the world’s population), genetic risk factors for certain diseases and conditions are more accurate for that population. But results from African genome studies are revealing information that may be beneficial for larger populations.

For example, up to 2% of African genomes contain mutations in the PCSK9 gene, which are related to lower cholesterol levels over a person’s lifetime. The finding has led to the development of cholesterol-lowering medications for Africans and other human populations worldwide. And Huntington’s disease is associated with at least two genes in African patients versus only one gene in patients with European ancestry. Understanding why such mutations are differentially prevalent in African and diverse populations can provide insights into better diagnosis and care for sickle-cell disease, heart disease, high cholesterol, Huntington’s, and many other diseases and conditions.

In his lecture, Wonkam also stressed the need to investigate the origins of “ghost DNA,” which is estimated to have been introduced into modern human genomes about 24,000 years ago. Some DNA markers derived from Neanderthal ancestors have recently been shown to make up about 2% to 4% of genomes of people of European descent, making them more susceptible to COVID-19 and other immunological conditions than people of African descent (Nature 587:610-612, 2020). Studying African genomes would help us understand why.

Implications

In an interview with The NIH Catalyst, Charles Rotimi discussed how the American landscape is shaped by African genomics. Rotimi, who is also the Director of the trans-NIH Center for Research on Genomics and Global Health, regularly uses data from African American study participants as controls to explore the evolutionary contexts of diseases, especially in his work on triglycerides.

Charles Rotimi

Charles Rotimi

Using genetic sequencing, Rotimi and his group found that African Americans who have higher concentrations of triglycerides in their blood are likely to have higher proportions of European ancestry in genes associated with triglycerides. This finding shows how crucial Rotimi’s work is to developing a better understanding of how the complex ancestral backgrounds of African Americans compared with West Africans and Europeans can inform health disparities here in the United States. Rotimi and Wonkam are both interested in epigenetic changes to the genome. Their work suggests that studying African genomics can further our understanding of modern medicine.

“African genomic variation is the next frontier of global genetic medicine,” Wonkam proclaimed during his talk.


To watch a videocast of Ambroise Wonkam’s WALS lecture “Harnessing African Genomic Variation to Improve Health Globally,” held on September 14, 2022, go to https://videocast.nih.gov/watch=45982.


Sreya Sanyal

Sreya Sanyal is a Postbaccalaureate Fellow in the National Institute of Dental and Craniofacial Research’s Proteases and Tissue Remodeling Section. She is studying the modification of anthrax toxin variants for use as a potential therapy for cancer. In her spare time, she likes to visit new restaurants, practice singing, and embroider.

This page was last updated on Thursday, March 16, 2023

  • Issue Overview
  • Features
    • Beauty Is in the Eye of the Gecko
    • The NIH Catalyst Celebrates 30 Years
    • Interview with John I. Gallin, M.D.
    • The Faucet of Youth
    • NINR’s New Scientific Director: Sabrina Wong, R.N., Ph.D.
    • Meet 18 New Stadtman Investigators
    • Inclusion of People with Disabilities in Technology Research and Development
    • Our Shared Ancestry in African Genomes Can Be Harnessed to Improve Health For All
    • What We’re Reading
    • COVID-19 Timeline at NIH (January-February 2023)
  • Departments
    • From the Deputy Director for Intramural Research
    • Commentary
    • News Briefs
    • Research Briefs
    • The Training Page
    • News You Can Use: Technology Transfer
    • The SIG Beat: Psychedelic Medicine
    • The SIG Beat: New SIGS
    • Photographic Moment
    • Announcements: Kudos
    • Announcements
  • Issue Contents
  • Download this issue as a PDF

Catalyst menu

  • Current Issue
  • Previous Issues
  • About The NIH Catalyst
  • Contact The NIH Catalyst
  • Share Your Story
  • NIH Abbreviations

Subscribe Today!

Subscribe to The NIH Catalyst Newsletter and receive email updates.

Subscribe

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search